Interventions for HIV-associated nephropathy

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 1, 2013, Pages

  Yahaya, Ismail ^a,b   Uthman, Olalekan A ^c   Uthman, Muhammed Mubashir B ^d  

^a Save the Youth Initiative   (Nigeria)

^b MID SWEDEN UNIVERSITY   (Sweden)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

^d UNIVERSITY OF ILORIN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIRETROVIRUS AGENT; CORTICOSTEROID; CYCLOSPORINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLATE MOFETIL; PREDNISOLONE;

ALL CAUSE MORTALITY; ANTIRETROVIRAL THERAPY; DISEASE SEVERITY; HIV ASSOCIATED NEPHROPATHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW;

EID: 84938493396     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007183.pub3     Document Type: Review

References (42)

1. Burns GC, Paul SK, Toth IR, Sivak SL. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. Journal of the American Society of Nephrology 1997;8(7):1140-6. [MEDLINE: 9219164]
2. Cosgrove CJ, Abu-Alfa AK, Perazella MA. Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy. American Journal of the Medical Sciences 2002;323(2):102-6. [MEDLINE: 11863077]
3. Eustace JA, Nuermberger E, Choi M, Scheel PJ, Moore R, Briggs WA. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney International 2000;58(3):1253-60. [MEDLINE: 10972688]
4. Kalayjian R, Phinney M, Austen J, Gripshover B, Carey J, Rahman M, et al.Prednisone improves renal function in HIV-associated nephropathy (HIVAN). Program and Abstracts of the Second National Congress on Human Retroviruses and Related Infections. Washington, DC: American Society for Microbiology, 1995:154. [: ISBN: 1555810977]
5. Kalayjian RC, Franceschini N, Gupta SK, Szczech LA, Mupere E, Bosch RJ, et al.Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS 2008;22(4):481-7. [MEDLINE: 18301060]
6. Kimmel PL, Mishkin GJ, Umana WO. Captopril and renal survival in patients with human immunodeficiency virus nephropathy. American Journal of Kidney Diseases 1996;28(2):202-8. [MEDLINE: 8768914]
7. Peters PJ, Moore DM, Mermin J, Brooks JT, Downing R, Were W, Kigozi A, Buchacz K, Weidle PJ. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney International 2008;74(7):925-9.
8. Smith M, Pawar R, Carey J, Graham R, Jacobs G, Menon A, et al.Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy (HIV-AN). American Journal of Medicine 1994;97(2):145-51. [MEDLINE: 8059780]
9. Smith MC, Austen JL, Carey JT, Emancipator SN, Herbener T, Gripshover B, et al.Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. American Journal of Medicine 1996;101(1):41-8. [MEDLINE: 8686713]
10. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, et al.The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney International 2004;66(3):1145-52. [MEDLINE: 15327410]
11. Wei A, Burns GC, Williams BA, Mohammed NB, Visintainer P, Sivak SL. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney International 2003;64(4):1462-71. [MEDLINE: 12969167]
12. Keryx Biopharmaceuticals. Keryx Biopharmaceuticals to initiate Phase II clinical trial of KRX-101 for the treatment of AIDS-related kidney disease - HIV-associated nephropathy (HIVAN): HIVAN is a life-threatening complication of AIDS (published January 29th 2001). http://investors.keryx.com/phoenix.zhtml?c=122201&p=irol-newsArticle_print&ID=869589&highlight= (accessed 29 October 2012).
13. Kalayjian R, Smith MC, Lederman M. A phase II randomised, double-blind, placebo-controlled trial to determine the efficacy of prednisolone therapy in HIV-Associated Nephropathy (HIVAN). http://www.clinicaltrials.gov/ct2/show/NCT00000819 (accessed 29 October 2012).
14. Kopp JB. Retinoids for minimal change disease and focal segmental glomerulosclerosis. http://www.clinicaltrials.gov/ct2/show/NCT00098020 (accessed 29 October 2012).
15. A study of Saquinavir soft gel capsules (SGC) used in combination with two other anti-HIV drugs in patients with HIV-Associated kidney disease. http://www.clinicaltrials.gov/ct2/show/NCT00002397 (accessed 29 October 2012).
16. Szczech LA. A phase III, randomized, placebo-controlled, double-blind trial of an angiotensin receptor blocker (valsartan) and highly active antiretroviral therapy (HAART) versus HAART alone for the treatment of HIV-associated nephropathy. http://clinicaltrials.gov/ct2/show/NCT00089518 (accessed 29 October 2012).
17. Abbott KC, Hypolite I, Welch PG, Agodoa LY. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era. Journal of Nephrology 2001;14(5):377-83. [MEDLINE: 11730270]
18. Ahuja TS, Borucki M, Funtanilla M, Shahinian V, Hollander M, Rajaraman S. Is the prevalence of HIV-associated nephropathy decreasing?. American Journal of Nephrology 1999;19(6):655-9. [MEDLINE: 10592359]
19. Atta MG, Gallant JE, Rahman MH, Nagajothi N, Racusen LC, Scheel PJ, et al.Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrology Dialysis Transplantation 2006;21(10):2809-13. [MEDLINE: 16864598]
20. Atta MG, Lucas GM, Fine DM. HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management. Expert Review of Antiinfective Therapy 2008;6(3):365-71. [MEDLINE: 18588500]
21. Berliner AR, Fine DM, Lucas GM, Rahman MH, Racusen LC, Scheel PJ, et al.Observations on a cohort of HIV-infected patients undergoing native renal biopsy. American Journal of Nephrology 2008;28(3):478-86. [MEDLINE: 18176076]
22. Carbone L, D'Agati V, Cheng JT, Appel GB. Course and prognosis of human immunodeficiency virus-associated nephropathy. American Journal of Medicine 1989;87(4):389-95. [MEDLINE: 2801729]
23. Estrella ME, Fine DM, Gallant JE, Rahman MH, Nagajothi N, Racusen LC, et al.HIV Type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients. Clinical Infectious Diseases 2006;43(3):1488-95. [MEDLINE: 16804855]
24. Fine DM, Perazella MA, Lucas GM, Atta MG. Renal disease in patients with HIV infection: epidemiology, pathogenesis and management. Drugs 2008;68(7):963-80. [MEDLINE: 18457462]
25. Gerntholtz TE, Goetsch SJ, Katz I. HIV-related nephropathy: a South African perspective. Kidney International 2006;69(10):1885-91. [MEDLINE: 16625149]
26. Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, et al.Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008;300(5):555-70. [MEDLINE: 18677028]
27. Han TM, Naicker S, Ramdial PK, Assounga AG. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney International 2006;69(12):2243-50. [MEDLINE: 16672914]
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [MEDLINE: 12958120]
29. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
30. Ingulli E, Tejani A, Fikrig S, Nicastri A, Chen CK, Pomrantz A. Nephrotic syndrome associated with acquired immunodeficiency syndrome in children. Journal of Pediatrics 1991;119(5):710-6. [MEDLINE: 1941375]
31. Khan S, Haragsim L, Laszik ZG. HIV-associated nephropathy. Advances in Chronic Kidney Disease 2006;13(3):307-13. [MEDLINE: 16815235]
32. Kopp JB, Winkler C. HIV-associated nephropathy in African Americans. Kidney International - Supplement 2003, (83):S43-9. [MEDLINE: 12864874]
33. Lai CF, Huang JW, Lin WC, Hung CC, Chu TS. Human immunodeficiency virus-associated nephropathy. Journal of the Formosan Medical Association 2006;105(8):680-4. [MEDLINE: 16935771]
34. Lochner ML, Wolf A. Human immunodeficiency virus-1 associated nephropathy (HIVAN): epidemiology, pathogenesis, histology, diagnosis, and medical management. Nephrology Nursing Journal: Journal of the American Nephrology Nurses' Association 2006;33(3):259-67. [MEDLINE: 16859198]
35. Lu TC, Ross M. HIV-associated nephropathy: a brief review. Mount Sinai Journal of Medicine 2005;72(3):193-9. [MEDLINE: 15915314]
36. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004;18(3):541-6. [MEDLINE: 15090808]
37. Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, et al.Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. New England Journal of Medicine 1984;310(11):669-73. [MEDLINE: 6700641]
38. Roling J, Schmid H, Fischereder M, Draenert R, Goebel FD. HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clinical Infectious Diseases 2006;42(10):1488-95. [MEDLINE: 16619164]
39. Szczech LA, Hoover DR, Feldman JG, Cohen MH, Gange SJ, Gooze L, et al.Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clinical Infectious Diseases 2004;39(8):1199-206. [MEDLINE: 15486845]
40. Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney International 1999;55(3):1036-40. [MEDLINE: 10027941]
41. Yahaya I, Uthman AO, Uthman MMB. Adjunctive therapies for HIV-associated nephropathy. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD007183]
42. Yahaya I, Uthman OA, Uthman MM. Interventions for HIV-associated nephropathy. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD007183.pub2]